Matinas BioPharma Holdings, Inc.

MTNB · NYSE · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 2 employees
225
SEC Filings
$0.178
Close 2026-09-24
2
Employees

Business Summary

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company focused on its lipid nanocrystal (LNC) platform delivery technology. Its lead product candidate, MAT2203, is an oral formulation of amphotericin B for treating life-threatening invasive fungal infections. Following a Phase 2 trial in cryptococcal meningitis, MAT2203 is positioned for a Phase 3 trial (ORALTO) for invasive aspergillosis. After an 80% workforce reduction in October 2024, the company paused clinical development and is seeking licensing or partnership transactions.

Latest Stock Quote

MTNB 2026-09-24 $0.178 O:$0.175 H:$0.179 L:$0.1712 Vol:0.2M VWAP:$0.1742
origin leaf: null

Next Earnings

expected 2026-12-04

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001493152-26-014132EDGAR78K words
2025-04-152024-12-310001641172-25-004882EDGAR74K words
2024-03-272023-12-310001493152-24-011493EDGAR84K words
2023-03-152022-12-310001493152-23-007726EDGAR82K words
2022-03-082021-12-310001493152-22-006231EDGAR83K words
2021-03-292020-12-310001493152-21-006979EDGAR93K words
2020-03-092019-12-310001493152-20-003558EDGAR90K words
2019-04-012018-12-310001493152-19-004560EDGAR91K words
2018-03-162017-12-310001493152-18-003518EDGAR88K words
2017-03-312016-12-310001144204-17-018184EDGAR84K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-132026-06-300001493152-26-037748EDGAR20K words
2025-11-102025-09-300001493152-25-021506EDGAR17K words
2025-08-142025-06-300001641172-25-024014EDGAR16K words
2025-05-152025-03-310001641172-25-011026EDGAR15K words
2024-11-132024-09-300001493152-24-045201EDGAR16K words
2024-08-142024-06-300001493152-24-032144EDGAR15K words
2024-05-092024-03-310001493152-24-018417EDGAR13K words
2023-11-082023-09-300001493152-23-039892EDGAR16K words
2023-08-092023-06-300001493152-23-027340EDGAR15K words
2023-05-102023-03-310001493152-23-016151EDGAR14K words
2022-11-022022-09-300001493152-22-030195EDGAR17K words
2022-08-112022-06-300001493152-22-021955EDGAR17K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-280001493152-26-044451EDGAR1K words
2026-09-160001493152-26-042954EDGAR1K words
2026-09-040001493152-26-041577EDGAR1K words
2026-07-240001493152-26-034601EDGAR1K words
2026-07-130001493152-26-032938EDGAR3K words
2026-04-030001493152-26-015170EDGAR1K words
2026-01-230001493152-26-003445EDGAR1K words
2025-12-120001493152-25-027529EDGAR1K words
2025-11-210001493152-25-024691EDGAR1K words
2025-08-180001641172-25-024520EDGAR3K words

225 total filings indexed. 193 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

invasive-fungal-infections oncology inflammatory-diseases immunocompromised-patients

Company Identity

CIK0001582554
TickerMTNB
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.matinasbiopharma.com
Listed2014-07-21

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 641e7fdfd1acb5ba87e6fb2b29398ccc4ad6ce67ace171bd14c04eaa85a3783a
parent: d6582d882da463c33ea30da32d4708bea9b552355dbdae21730fc90cc0435280
content hash: a15cbdfaf8cd7253413483c394f1c92519a4c65c7ae479c44835acc2bf1e9e87
signed: 2026-10-13T19:02:23.107Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up MTNB using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on MTNB, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/MTNB (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.